worldwid
infecti
diseas
infecti
bronchiti
caus
huge
econom
loss
poultri
product
system
etiolog
agent
infecti
bronchiti
viru
ibv
coronaviridaefamili
gammacoronaviru
whose
genom
positivesens
singlestrand
rna
kb
length
ibv
four
structur
protein
membran
nucleocapsid
n
envelop
e
spike
latter
cleav
two
subunit
princip
antigen
gener
neutral
host
cellular
receptor
therefor
determin
viru
tropism
attach
entir
protein
viru
nonstructur
protein
coronavirus
exonucleas
activ
keep
control
error
rate
replic
process
although
allow
gener
divers
evolut
adapt
thu
contribut
emerg
new
strain
identif
three
hypervari
region
hvr
along
reason
way
evalu
structur
chang
therebi
determin
homolog
differ
strain
understand
chang
primari
sequenc
region
approach
conform
chang
observ
tertiari
one
final
respons
evolut
immun
escap
viru
ibv
control
primarili
vaccin
howev
continu
appear
new
strain
differ
countri
around
world
necessit
assess
upgrad
vaccin
program
case
mean
widen
protectotyp
ad
strain
ibv
first
describ
chile
massachusett
mass
strain
vaccin
author
ministri
agricultur
sever
outbreak
report
flock
receiv
mass
vaccin
latter
character
strain
classifi
lineag
henc
ministri
agricultur
approv
introduct
vaccin
even
though
serotyp
present
chile
sever
studi
demonstr
efficaci
protectotyp
heterolog
strain
howev
consequ
introduc
vaccin
strain
present
countri
debat
point
work
aim
determin
antigen
genet
variabl
ibv
sampl
isol
outbreak
commerci
flock
examin
relationship
vaccin
introduc
chile
period
embryon
chicken
egg
experiment
spf
flock
use
hen
belong
white
leghorn
breed
receiv
type
vaccin
includ
ibv
kept
strict
biosafeti
condit
moreov
egg
routin
monitor
ibv
antibodi
accord
method
describ
polson
brief
yolk
mix
chloroform
centrifug
procedur
perform
twice
aqueou
supernat
test
ibv
use
commerci
elisa
kit
idexx
egg
use
viru
isol
incub
obtain
onedayold
chick
protect
test
produc
hyperimmun
serum
studi
involv
eight
ibv
isol
differ
outbreak
commerci
chicken
flock
isol
obtain
mass
vaccin
live
attenuatedinactiv
vaccin
appli
chilean
poultri
sampl
obtain
tracheal
swab
broiler
breeder
whose
flock
show
respiratori
sign
drop
egg
product
viru
isol
four
year
introduct
vaccin
chilean
product
system
sampl
tracheal
swab
broiler
whose
flock
exhibit
inflamm
infraorbit
mucou
membran
bilater
facial
edema
abund
palatin
pharyng
secret
nephrosi
final
four
virus
isol
six
year
approv
vaccin
isol
two
flock
lay
hen
exhibit
tracheal
secret
enlarg
kidney
urat
renal
parenchyma
uric
acid
deposit
pericardium
liver
intestin
virus
isol
broiler
flock
day
tracheal
secret
sampl
tracheal
swab
addit
aforement
sampl
mass
commerci
vaccin
also
includ
studi
sampl
flock
belong
chilean
central
zone
poultri
industri
major
develop
complet
zone
also
sever
outbreak
vaccin
poultri
later
describ
strain
sampl
use
inocul
six
embryon
egg
h
post
inocul
pi
nonspecif
mortal
remov
three
egg
sacrif
h
pi
obtain
chorioallanto
fluid
subsequ
passag
three
four
passag
perform
accord
gelb
et
al
lesion
compat
stunt
curl
club
urat
deposit
observ
sampl
confirm
rtpcr
viral
extract
sampl
perform
viral
rnadna
mini
kit
invitrogen
usa
accord
manufactur
instruct
full
segment
bp
amplifi
primer
describ
zhang
et
al
rtpcr
perform
use
iii
onestep
kit
invitrogen
usa
follow
paramet
min
min
cycl
final
extens
step
min
ad
rtpcr
product
visual
agaros
gel
purifi
use
quick
gel
extract
kit
accord
manufactur
instruct
final
abi
genet
analyz
use
sequenc
process
align
calcul
nucleotid
sequenc
perform
mafft
softwar
use
linsi
method
nucleotid
model
substitut
identifi
use
jmodeltest
softwar
maximumlikelihood
tree
construct
onlin
platform
phyml
use
dataset
previous
publish
valastro
et
al
final
aminoacid
sequenc
align
use
bioedit
accord
result
obtain
molecular
character
three
isol
select
consid
lineag
isol
year
serotypespecif
antisera
prepar
chick
field
virus
well
attenu
mass
vaccin
purchas
local
msd
repres
virus
inactiv
vv
formalin
h
shake
mix
complet
incomplet
freund
adjuv
first
two
week
old
second
four
week
old
inocul
respect
via
subcutan
two
week
last
inocul
chick
sacrif
blood
harvest
sera
obtain
inactiv
min
antibodi
level
evalu
use
commerci
elisa
kit
idexx
cross
virusneutr
test
mass
conduct
embryon
egg
eight
serial
tenfold
viru
dilut
prepar
tryptos
soya
broth
tsb
mix
equal
proport
challeng
sera
min
incub
five
embryon
egg
inocul
dilut
embryon
egg
sacrif
seven
day
pi
lesion
record
infect
titer
calcul
determin
chicken
embryo
infect
dose
accord
method
valu
neutral
index
ni
estim
use
differ
titer
log
two
strain
related
valu
r
calcul
use
method
classifi
accord
brooksbi
criteria
mean
antigen
ident
lesser
differ
r
minor
chang
subtyp
r
major
chang
subtyp
r
serotyp
chang
r
phase
aim
evalu
protect
vaccin
singl
administr
three
field
isol
studi
sixti
onedayold
spf
chick
receiv
blood
sampl
drawn
test
ibv
antibodi
use
idexx
commerci
kit
chick
immun
vaccin
nasal
instil
chick
divid
equal
four
group
hous
differ
isol
room
control
access
high
level
biosafeti
three
week
old
three
four
vaccin
group
challeng
least
virus
nasal
instil
nonchalleng
control
group
last
group
inocul
distil
water
health
statu
chick
monitor
daili
six
day
pi
sacrif
tracheal
swab
taken
store
viral
recoveri
could
quantifi
rtqpcr
final
complet
necropsi
perform
bird
viral
extract
perform
viral
rnadna
mini
kit
invitrogen
usa
accord
manufactur
instruct
segment
bp
n
gene
sequenc
amplifi
use
newli
develop
primer
norox
onestep
kit
biolin
follow
paramet
min
min
cycl
standard
curv
develop
triplic
six
tenfold
serial
dilut
purifi
amplicon
begin
quantifi
spectrophotomet
biotek
usa
effici
reaction
r
reach
valu
melt
curv
analysi
conduct
rais
melt
peak
primerdim
nonspecif
product
detect
test
use
compar
optic
densiti
od
differ
sera
obtain
viru
neutral
test
test
use
verifi
normal
distribut
cycl
threshold
ct
valu
rtqpcr
protect
test
tukey
multipl
comparison
test
use
compar
ct
valu
group
aforement
test
perform
rstudio
softwar
version
rstudio
team
nucleotid
sequenc
data
report
paper
submit
genbank
databas
access
number
assign
isol
isol
cluster
togeth
lineag
figur
accord
valastro
et
al
author
includ
lineag
strain
previous
known
previous
describ
south
america
howev
isol
group
separ
lineag
figur
strain
describ
figur
show
aminoacid
differ
field
strain
mass
vaccin
current
appli
chile
mark
differ
observ
describ
hypervari
region
strain
isol
mass
vaccin
remark
similitud
virus
isol
vaccin
observ
especi
isol
four
aminoacid
figur
verifi
along
whole
aminoacid
sequenc
similarli
found
three
aminoacid
differ
vaccinelik
viru
vaccin
chang
posit
count
start
open
read
frame
gene
glycin
glutam
acid
identifi
though
virus
isol
lay
hen
week
last
applic
ibv
live
attenu
vaccin
lack
virul
marker
remain
current
issu
presum
vaccin
reisol
despit
de
wit
review
field
virus
vaccin
recoveri
week
long
period
mainli
fece
viral
recoveri
trachea
kidney
significantli
lower
cavanagh
et
al
show
passag
chick
produc
chang
posit
alanin
serin
observ
furthermor
isol
obtain
outbreak
commerci
flock
exhibit
clinic
sign
fortuit
isol
final
flock
neg
common
respiratori
pathogen
thu
isol
appear
wild
virus
deriv
vaccin
emerg
unquantifi
number
passag
within
flock
result
obtain
phylogenet
studi
cluster
two
lineag
field
virus
consid
differ
year
isol
three
field
virus
chosen
develop
viru
neutral
protect
test
isol
introduct
virus
isol
introduct
elisa
test
detect
neutral
antibodi
chick
inocul
field
virus
well
mass
vaccin
sampl
reach
sp
valu
cutoff
point
provid
kit
manufactur
tabl
thu
possibl
prove
product
hyperimmun
serum
success
signific
differ
level
optic
densiti
achiev
pvalu
differ
group
brooksbi
criterion
use
classifi
antigen
relationship
unveil
archettihorsfal
method
field
strain
mass
vaccin
minor
chang
subtyp
detect
viru
mass
vaccin
tabl
outbreak
occur
flock
previous
vaccin
mass
strain
nonetheless
previou
assay
shown
effici
protectotyp
justifi
introduct
scarc
relat
vaccin
antigen
relationship
observ
strain
two
vaccin
also
low
final
among
field
strain
minor
chang
subtyp
shown
reaction
hand
high
antigen
relationship
observ
viru
vaccin
noteworthi
use
brooksbi
criterion
minor
chang
found
two
result
align
present
moor
et
al
show
least
amino
acid
residu
would
relat
neutral
serotypespecif
epitop
studi
vaccin
viru
show
high
antigen
relationship
also
shown
share
aspart
acid
posit
well
virus
isol
serin
found
field
virus
figur
result
present
support
find
publish
moor
et
al
author
show
chang
one
two
specif
residu
enough
neutral
neutral
specif
strain
elisa
test
perform
onedayold
chick
use
protect
test
show
ibneutr
antibodi
prior
vaccin
control
group
show
clinic
sign
presenc
viru
detect
rtqpcr
bird
challeng
virus
show
clinic
sign
compat
ib
h
pi
mainli
inflam
infraorbit
sinus
tracheal
rale
addit
necropsi
bird
challeng
strain
show
lesser
presenc
mucos
upper
respiratori
tract
compar
observ
two
group
present
larg
amount
mucos
remain
organ
exhibit
appar
lesion
addit
challeng
show
clinic
sign
entir
assay
result
summar
tabl
tabl
present
ct
valu
rtqpcr
perform
tracheal
swab
bird
challeng
three
field
virus
valu
rang
group
challeng
strain
meanwhil
chicken
challeng
viru
final
higher
rang
regist
group
challeng
viru
ct
valu
valu
accord
result
present
fellahi
et
al
valid
rtqpcr
target
bp
n
gene
ct
valu
show
normal
distribut
test
pvalu
differ
ct
valu
rtqpcr
perform
group
bird
challeng
strain
pvalu
figur
hand
ct
valu
rtqpcr
swab
obtain
bird
challeng
viru
significantli
higher
amount
recov
group
challeng
pvalu
pvalu
isol
figur
data
align
clinic
sign
lesion
observ
thu
higher
ct
rtqpcr
perform
bird
challeng
viru
show
sampl
lower
initi
viral
amount
effici
inhibit
viral
replic
vaccin
studi
evalu
eight
isol
infecti
bronchiti
viru
obtain
differ
year
analysi
genet
sequenc
allow
choos
three
evalu
antigen
protect
chang
relat
vaccin
antigen
minor
variat
subtyp
establish
isol
mass
vaccin
virus
type
antigen
relationship
describ
isol
vaccin
tabl
field
virus
belong
lineag
figur
expect
share
type
antigen
relationship
vaccin
despit
isol
six
year
apart
thu
differ
residu
observ
figur
enough
cluster
apart
virus
thu
conclud
aminoacid
chang
observ
two
field
strain
figur
residu
critic
chang
affin
mass
vaccin
strain
isol
china
shown
mainli
respiratori
sign
diarrhea
plu
proventriculu
lesion
hand
chilean
strain
exhibit
respiratori
sign
renal
lesion
although
viru
could
isol
proventriculu
shown
despit
differ
biolog
behavior
chilean
virus
strain
isol
china
combin
mass
vaccin
provid
good
level
protect
virus
isol
chile
support
introduct
vaccin
chile
recent
de
wit
et
al
shown
better
level
protect
achiev
appli
inactiv
ib
vaccin
prior
stimul
attenu
mass
vaccin
along
line
chilean
poultri
produc
adopt
strategi
vaccin
chick
attenu
mass
vaccin
rear
period
end
period
use
inact
mass
vaccin
shown
effect
given
clinic
outbreak
mainli
control
howev
six
year
introduct
vaccin
virus
isol
classifi
along
vaccin
figur
moreov
replic
viru
inhibit
vaccin
compar
viral
replic
obtain
virus
figur
result
present
consist
liu
et
al
show
bird
vaccin
ib
challeng
homolog
strain
well
protect
hand
challeng
heterolog
strain
protect
gener
variabl
lower
expect
possibl
verifi
recent
introduc
vaccin
provid
better
protect
strain
isol
genet
antigen
relat
immun
respons
would
mainli
respons
differ
protect
level
howev
measur
elucid
specif
role
avian
immun
system
although
discuss
whether
introduct
vaccin
appropri
control
clinic
problem
observ
field
appear
lineag
reopen
question
regard
anthropomorph
role
dissemin
differ
strain
locat
describ
natur
cook
et
al
propos
new
strategi
address
constant
emerg
new
two
heterolog
vaccin
develop
protectotyp
order
stimul
immun
respons
neutral
differ
pathogen
strain
first
combin
describ
use
mass
vaccin
strain
combin
could
also
effect
studi
protect
vaccin
concept
protectotyp
rather
evalu
serotyp
genotyp
present
reason
solut
howev
constant
object
elucid
relationship
genotyp
serotyp
protectotyp
vital
case
minim
chang
one
characterist
produc
signific
chang
anoth
increas
protect
grant
combin
heterolog
mass
vaccin
alreadi
proven
result
vaccin
introduc
differ
countri
even
pathogen
variant
previous
describ
furthermor
time
resourc
requir
vaccin
develop
make
continu
gener
new
vaccin
seem
inviabl
commerci
scale
date
ibv
vaccin
attenu
process
involv
passag
embryon
egg
littl
known
aminoacid
residu
involv
loss
virul
shimazaki
et
al
found
aminoacid
chang
posit
similar
field
isol
thu
could
involv
virul
revers
vaccin
oad
et
al
found
embryon
egg
attenu
process
gener
differ
genom
pattern
differ
attenu
viral
popul
verifi
low
level
consensu
among
revers
virul
achiev
differ
unpredict
way
facilit
high
rate
mutat
describ
ibv
data
support
grow
concern
introduct
attenu
vaccin
pathogen
variant
previous
describ
studi
initi
approach
understand
whether
recent
introduc
vaccin
capac
modifi
least
part
virus
circul
field
local
sanitari
servic
consid
inform
show
author
introduct
foreign
strain
countri
howev
previou
statement
impli
develop
new
approach
vaccin
elabor
instead
use
current
vaccin
remind
keep
poultri
health
without
forget
must
longterm
way
comprehens
understand
wholegenom
approach
must
taken
clarifi
whether
proxim
field
strain
due
vaccin
revers
mutat
andor
one
recombin
process
involv
vaccin
strain
proven
escap
contribut
genet
materi
field
virus
deep
epidemiolog
approach
also
requir
evalu
current
statu
viral
popul
determin
mani
strain
cocircul
possibl
domin
hierarchi
establish
among
